Fanconi Anemia: What If There Aren't Good Transplant Options?

Tuesday, June 18, 2024, 8:00 AM - 9:00 AM, Marlo Thomas Center Lecture Hall, Memphis, TN

The purpose of the LLH/BMTCT Conference is to update knowledge related to the diagnosis and treatment of pediatric malignant and benign hematologic diagnoses, bone marrow transplantation and  cellular therapies; promote interaction among health care providers, research staff and clinical investigators; and use case presentation followed by literature review and open plenary discussion to improve audience members' performance in an education setting.

Objective(s):
Location: St. Jude Children's Research Hospital
Specialties: Hematology, Oncology, Pediatrics, Pharmaceutical Sciences, Palliative Care, Infectious Diseases, Bone Marrow Transplant/Cellular Therapy, Immunology, Pharmaceutical Services, Global Pediatric Medicine

Faculty Disclosures:
Senthil Velan Bhoopalan, MBBS (Nothing to disclose - 05/21/2024)
Download Handout

1. Describe the clinical symptoms and genetic characteristics of Fanconi Anemia through the analysis of a patient presentation
2. Discuss the mechanisms and genetic mutations underlying Fanconi Anemia and the role of specific pathways on the disease.
3. Explain current treatment options and recent advancements in bone marrow transplantation, gene therapy, and supportive care approaches in Fanconi Anemia.

St. Jude Children's Research Hospital is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

St. Jude Children’s Research Hospital designates this Live Activity for a maximum of 1.00 AMA PRA Category 1 Credits^TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

AMA PRA Category 1 Credits™ (1.00 hours), Non-Physician Attendance (1.00 hours)

Mitigation of Relevant Financial Relationships

St Jude Children's Research Hospital adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others, are required to disclose all financial relationships with ineligible entities (ie, companies whose primary business is producing, marketing, selling, re-selling, or distributing health care products used by or on patients). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Date	Empty Column	Title
		No activities are currently published for this month.
No upcoming dates have been setup.